obesity-995x60.png
FEATURED ARTICLES
The Case For Research-Naive PIs
Carrie Lewis, executive director, clinical program optimization, at Keenova (formerly Endo) explains why research-naive PIs may improve trial quality, challenge assumptions about ROI, and help fix a shrinking investigator pipeline.
-
Agentic AI Is Transforming Life Sciences Discovery And Operations
73% of pharma companies are planning or deploying agentic AI. Discover who’s leading and how intelligent agents are transforming R&D.
-
FDA Pushes For Patient Voice: ePRO In Oncology Trials
FDA urges sponsors and CROs to include patient voices in oncology trials. Discover why it matters and how to start integrating this approach.
-
How A Strategic Bioanalysis CRO Partnership Empowers Sponsors
Choosing the right bioanalysis CRO is vital to avoid costly delays. Sponsors need evaluation strategies that prioritize proven quality, predictable timelines, and submission-ready data.